Free Scientist in Molecular Biology - MB(ASCP) Practice Questions
200 free questions · Answer explanations · No signup required
View examination details, outline and sourcesLoading selected examination banks…
Sample Practice Questions
Try these 10 sample questions from the Scientist in Molecular Biology - MB(ASCP) practice bank. Each includes the answer and explanation. Continue with the interactive practice above to review the full question set.
1Which sugar is part of an RNA nucleotide?
2In silica column purification, which condition promotes nucleic acid binding to the silica membrane?
- A. High chaotropic salt concentration
- B. Low salt elution buffer
- C. Proteinase K digestion alone
- D. RNase A digestion alone
3For an open-tube molecular amplification workflow, in which direction should personnel and materials move to reduce amplicon carryover?
- A. From clean pre-amplification areas to post-amplification areas
- B. From product detection back to reagent preparation
- C. In either direction when negative controls are included
- D. From amplicon storage into specimen extraction
Answer: A
Explanation: CDC False-Positive Investigation Toolkit: Prevention Practices states "This practice ensures that work moves from clean (pre-amplification) to dirty (post- amplification) areas and decreases the potential for carryover or backflow contamination of amplicons." Thus from clean pre-amplification areas to post-amplification areas is the supported interpretation for this laboratory circumstance.
Reference: CDC False-Positive Investigation Toolkit: Prevention Practices — Unidirectional workflow
4A C. difficile PCR assay is positive in a patient without diarrhea or other compatible symptoms. What limits the result's interpretation?
- A. Molecular positivity can reflect colonization without infection
- B. Molecular positivity alone confirms symptomatic CDI
- C. Molecular positivity directly quantifies free stool toxin
- D. The result must be dismissed as assay contamination
Answer: A
Explanation: CDC Clinical Testing and Diagnosis for C. diff Infection states "Molecular assays can be positive for C. diff in asymptomatic individuals and those who do not have an infection." Therefore molecular positivity can reflect colonization without infection is supported for the stated clinical test.
Reference: CDC Clinical Testing and Diagnosis for C. diff Infection — Recommended tests, Molecular tests
5During RNA synthesis, which base takes the place of thymine in the nucleotide chain?
6During silica column purification, which step removes residual proteins and salts while the nucleic acid remains bound?
- A. Alcohol-based washing
- B. Low-salt elution
- C. RNA transcription
- D. DNA ligation
7In an amplification run, what problem is a no-template control intended to reveal?
- A. Contamination or background amplification without target template
- B. Loss of sensitivity from a low-copy patient specimen
- C. A mismatch between patient genotype and phenotype
- D. Incorrect interpretation of a positive patient result
Answer: A
Explanation: CDC Good Laboratory Practices for Molecular Genetic Testing states "inclusion of NTC samples in these procedures is essential for monitoring the test procedures and indicating whether measures taken to minimize cross-contamination are effective." Thus contamination or background amplification without target template is the supported interpretation for this laboratory circumstance.
Reference: CDC Good Laboratory Practices for Molecular Genetic Testing — Unidirectional workflow for molecular amplification procedures
8A laboratory receives stool for C. difficile PCR testing. What does a positive FDA-approved PCR result primarily indicate?
- A. Presence of a toxin-producing C. difficile organism
- B. A measured concentration of free toxin B
- C. A confirmed cause of every symptom in the patient
- D. The precise antibiotic susceptibility pattern
Answer: A
Explanation: CDC Clinical Testing and Diagnosis for C. diff Infection states "FDA-approved PCR assays are same-day tests that are highly sensitive and specific for the presence of a toxin-producing C. diff organism." Therefore presence of a toxin-producing c. difficile organism is supported for the stated clinical test.
Reference: CDC Clinical Testing and Diagnosis for C. diff Infection — Recommended tests, Molecular tests
9Which set of components makes up a nucleotide?
- A. Sugar, phosphate group, and nitrogenous base
- B. Sugar, amino acid, and nitrogenous base
- C. Phosphate group, amino acid, and nitrogenous base
- D. Sugar, phosphate group, and amino acid
10After binding and washing a silica column, which condition is used to release the nucleic acid?
- A. High chaotropic salt
- B. Low-salt water or TE buffer
- C. Phenol in the organic phase
- D. Proteinase K in lysis buffer
Topics in this practice bank
These topics describe the available practice for Scientist in Molecular Biology - MB(ASCP). Review the examination outline and its sources for scope and allocation details.
Molecular Science
- Nucleic Acid Chemistry
- Basic Molecular Theory
- Biochemical Reagents
- Genetics
Molecular Techniques
- Nucleic Acid Isolation
- Manipulation of RNA/DNA
- Separation and Detection
- Nucleic Acid Amplification
- Sequencing
- Other Techniques
Laboratory Operations
- Contamination
- Quality Assurance
- Guidelines and Regulations
- Personnel
- Safety
Applications of Molecular Testing
- Infectious Disease
- Oncology
- Genetics
- Other
How to use these free practice questions
Choose an answer, check the explanation, and review your progress by chapter. Practice questions and explanations are free to access without signing up.
These are independent study questions, not actual examination items. For examination requirements and official information, view Scientist in Molecular Biology - MB(ASCP) details.